Transdermal Research Pharm Laboratories
Pharmaceuticals, 4170 Mendenhall Oaks Pkwy, Long Island City, New York, 11101, United States, 1-10 Employees
Phone Number: 71********
Who is TRANSDERMAL RESEARCH PHARM LABORATORIES
Transdermal Research Pharm Laboratories, LLC (TRPL) is an R&D company founded in May 2013, which has state of art R&D facility located in Long Island City, NY. TRPL is focusing on develop...
Read More
-
Headquarters: 4170 Mendenhall Oaks Pkwy, Long Island City, New York, 11101, United States
-
Date Founded: 2013
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 8734
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from TRANSDERMAL RESEARCH PHARM LABORATORIES
Transdermal Research Pharm Laboratories Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Transdermal Research Pharm Laboratories
Answer: Transdermal Research Pharm Laboratories's headquarters are located at 4170 Mendenhall Oaks Pkwy, Long Island City, New York, 11101, United States
Answer: Transdermal Research Pharm Laboratories's phone number is 71********
Answer: Transdermal Research Pharm Laboratories's official website is https://trplllc.com
Answer: Transdermal Research Pharm Laboratories's revenue is Under $1 Million
Answer: Transdermal Research Pharm Laboratories's SIC: 8734
Answer: Transdermal Research Pharm Laboratories's NAICS: 325412
Answer: Transdermal Research Pharm Laboratories has 1-10 employees
Answer: Transdermal Research Pharm Laboratories is in Pharmaceuticals
Answer: Transdermal Research Pharm Laboratories contact info: Phone number: 71******** Website: https://trplllc.com
Answer: Transdermal Research Pharm Laboratories, LLC (TRPL) is an R&D company founded in May 2013, which has state of art R&D facility located in Long Island City, NY. TRPL is focusing on developing transdermal drug delivery systems for new chemical entities (NCE) and approved drug products. TRPL offers its sole expertise in developing Topical/Transdermal Drug delivery system as a pharmaceutical development solution for various disease models. Our scientific staff has more than 70 years of experience in developing Transdermal Drug delivery System. And we are capable of developing Transdermal/Topical formulations as per your needs. TRPL already rewarded with one patent and it was already out-licensed. In addition, TRPL already submitted two more patents, which is currently available for out-licensed and Four more patents are already in the pipeline which an be available for co-development. In four year spam, TRPL put three drug candidates in the clinical trial. Two candidate pass the Phase-I clinical trial and currently under review by FDA. Potential partners who are looking to deliver complex NCE or approved drug product through skin than our expertise and technology platforms will help to develop controlled and long-term released formulation to increase the bioavailability of their API. TRPL is also interested in providing fee-based contract service with other pharmaceutical companies or investors to bring their product to the market quickly.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month